Looking back at this year, perhaps what stands out most of all is the patient feedback we have received. This has been life-changing for many patients, with pain relief reported within days and accelerated wound healing. Two patients, Spencer and June immediately come to mind. Their quality of life was restored after using Accel-Heal Solo.

Transformative impacts

Spencer was bitten by an insect as a teenager and as a result had to manage chronic wounds, most of his adult life. Traditional therapies didn’t work and he didn’t see any change until he used Accel-Heal Solo to achieve wound closure. Spencer said: “A wound-free life is a much happier life. More patients deserve to benefit from this therapy now, it heals wounds and manages pain.”

June’s wound pain was so severe she was unable to complete everyday activities such as gardening and cleaning. Using Accel-Heal Solo has improved her life. “I was in quite a bad way and now I’m looking forward to enjoying my life again,” she said. See June’s story here.

Supporting professional education

Our commitment to professional education has grown and our attendance at international conferences has extended; In May we attended EWMA 2023 (European Wound Management Association conference ) in October the Abu Dhabi International Vascular Conference and in November the 2023 Wounds UK Annual Conference.

We were delighted to support the Society of Tissue Viability’s webinar on wound pain. This was led by Dr Amelia Swift, reader in Health Professional Education at the University of Birmingham alongside Sarah Gardener, Society of Tissue Viability Vice Chair. Key objectives of the webinar included the impact of wound pain on patients and the associated effects on their quality of life. In conclusion Dr Swift said: “The use of electrical stimulation wound therapy reduces wound pain by a significant amount quickly.”

Increasing clinical evidence

Clinical evidence supporting the use of electrical stimulation wound therapy continues to grow with 11 meta-analyses, 10 systematic reviews and 37 randomised controlled trials now published.

A poster/presentation at the Wounds UK meeting covered an unmet need – providing an alternative to the use of analgesics to manage uncontrolled wound pain. The presentation demonstrated as wound pain subsided using Accel-Heal Solo, the use of strong analgesics reduced and eventually stopped. See more here.

We are excited about the prospect of the full study being published next year and the potential of providing an innovative way to help manage wound pain and reduce the use of analgesics.

We look forward to supporting healthcare practitioners to improve patient outcomes in 2024.

Find your local accel-heal distributor